CompletedPhase 4NCT01524536

Steroid Treatment for Hypereosinophilic Syndrome

Studying Hypereosinophilic syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Principal Investigator
Paneez Khoury, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Intervention
prednisone(drug)
Enrollment
26 enrolled
Eligibility
7-100 years · All sexes
Timeline
20122020

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01524536 on ClinicalTrials.gov

Other trials for Hypereosinophilic syndrome

Additional recruiting or active studies for the same condition.

See all trials for Hypereosinophilic syndrome

← Back to all trials